ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 461 filers reported holding ASTRAZENECA PLC in Q3 2017. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $18,376,000 | -39.9% | 368,556 | -46.3% | 0.22% | -41.5% |
| Q3 2019 | $30,587,000 | -27.5% | 686,273 | -34.6% | 0.37% | -25.6% |
| Q2 2019 | $42,189,000 | +0.4% | 1,049,224 | +1.0% | 0.50% | -19.3% |
| Q1 2019 | $42,001,000 | -13.8% | 1,038,848 | -19.0% | 0.62% | -18.1% |
| Q4 2018 | $48,698,000 | -20.6% | 1,282,198 | -17.3% | 0.75% | -5.8% |
| Q3 2018 | $61,348,000 | -58.7% | 1,550,361 | -63.4% | 0.80% | -58.5% |
| Q2 2018 | $148,675,000 | -4.7% | 4,234,559 | -5.1% | 1.92% | +2.3% |
| Q1 2018 | $156,073,000 | +2.7% | 4,463,045 | +1.9% | 1.88% | +6.1% |
| Q4 2017 | $151,961,000 | +1.2% | 4,379,275 | -1.1% | 1.77% | -2.2% |
| Q3 2017 | $150,093,000 | +4.5% | 4,430,147 | +5.2% | 1.81% | +1.1% |
| Q2 2017 | $143,596,000 | +9.7% | 4,212,264 | +0.2% | 1.79% | +6.3% |
| Q1 2017 | $130,858,000 | +31.3% | 4,202,262 | +15.2% | 1.68% | +24.4% |
| Q4 2016 | $99,647,000 | -28.4% | 3,647,410 | -13.9% | 1.35% | -19.3% |
| Q3 2016 | $139,157,000 | +6.7% | 4,234,852 | -1.9% | 1.67% | +5.7% |
| Q2 2016 | $130,390,000 | +6.4% | 4,318,985 | -0.8% | 1.58% | +5.5% |
| Q1 2016 | $122,596,000 | -14.7% | 4,353,544 | +2.8% | 1.50% | -12.2% |
| Q4 2015 | $143,725,000 | +4.7% | 4,233,419 | -1.8% | 1.71% | +8.6% |
| Q3 2015 | $137,210,000 | +5.0% | 4,312,077 | +110.1% | 1.58% | +16.7% |
| Q2 2015 | $130,728,000 | -9.0% | 2,051,924 | -2.3% | 1.35% | -5.1% |
| Q1 2015 | $143,686,000 | +20.1% | 2,099,752 | +23.6% | 1.42% | -6.0% |
| Q4 2014 | $119,596,000 | -27.1% | 1,699,292 | -26.0% | 1.51% | -3.4% |
| Q3 2014 | $164,095,000 | -7.7% | 2,296,963 | -4.0% | 1.57% | -4.4% |
| Q2 2014 | $177,871,000 | -27.6% | 2,393,638 | -36.8% | 1.64% | -31.1% |
| Q1 2014 | $245,624,000 | +8.5% | 3,785,813 | -0.7% | 2.38% | +6.3% |
| Q4 2013 | $226,280,000 | +14.8% | 3,811,360 | +0.4% | 2.24% | +3.1% |
| Q3 2013 | $197,186,000 | +12.2% | 3,797,155 | +2.2% | 2.17% | +3.4% |
| Q2 2013 | $175,668,000 | – | 3,713,916 | – | 2.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |